Chronic-Care Vendor Growth Slows Enrollment Outlook
Employers and health plans buying digital diabetes and hypertension programs should watch for slower member additions in the fourth quarter.
Updated on Nov. 6, 2026 in Healthcare

Omada Health reported $91 million in third-quarter 2026 revenue, up 34% year-over-year, and raised its full-year revenue and adjusted EBITDA outlook. For digital health operators, the results show a company growing membership while its stock fell 19% after the earnings call.
Why it matters
Omada's results point to continued demand for employer- and payer-funded digital chronic-care programs, with membership reaching 1.1 million, up 36% year-over-year. The 19% stock decline reflects investor concern that new enrollments will moderate sequentially in the fourth quarter, a signal that growth in this segment may not be linear.
Omada reported $91 million in revenue and $12 million in adjusted EBITDA for the quarter, compared with $2 million a year earlier, while serving 1.1 million members. Its trailing 12-month revenue per member was $294, and 2026 revenue guidance is $344 million to $346 million.
The players
Omada Health
A digital health company that sells chronic-condition programs, including diabetes and hypertension care, to employers and health plans, and which went public in June 2025.
Health Care Services Corporation
A health insurer whose partnership with Omada is being expanded into three additional states, with launch expected in 2027.
Wei-Li Shao
The executive set to become chief executive officer of Omada Health on January 1, 2027.
The details
Omada's membership growth was driven by its diabetes and hypertension programs, which are sold to employers and health plans that pay for enrollment. The company also expanded its partnership with Health Care Services Corporation into three additional states, a move that the company expects will add an estimated 1.5 million covered lives at launch in 2027. Investors reacted to forward signals rather than the quarter itself: the stock fell after management indicated a longer selling season and a likely decline in members in the fourth quarter.
Timeline
June 2025: Omada went public.
Q3 2025: Omada reported a net loss of $3 million and adjusted EBITDA of $2 million.
November 2025: Omada launched its GLP-1 care companion solution.
Q3 2026: Omada reported its strongest quarter to date, with the stock dropping 19% the following Friday.
Jan. 1, 2027: Wei-Li Shao takes over as chief executive officer.
Market Landscape
Omada's results fit a pattern in which digital chronic-care companies that sell through employers and health plans are judged on forward enrollment rather than current revenue. The partnership expansion with Health Care Services Corporation shows payer relationships remain the key distribution channel for this segment.
Operators in healthcare services and employer benefits should track whether digital chronic-care vendors keep their enrollment pace as selling seasons lengthen, since that affects vendor pricing and renewal terms. Businesses that buy these programs for employees should review contract structures and membership-based pricing with qualified benefits advisers.
The takeaway
The core operating lesson is that growth in digital chronic-care programs is now priced on forward enrollment, not reported revenue alone. Operators who buy or sell these services should calendar the next quarter's membership data and watch whether the partnership expansion translates into covered lives as planned in 2027.
Further reading
For broader context on the sector, explore Healthcare coverage on We are Main Street.




